Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone for delaying onset of mild cognitive impairment due to Alzheimer's disease in cognitively normal older adults
2012-003111-58Phase 3Completed
- Sponsor
- Takeda
- Start
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pioglitazone in Alzheimer's disease (AD), mild cognitive impairment due to Alzheimer's disease, sponsored by Takeda. Started May 2013; status: completed.
02
Drugs
pioglitazone
03
Conditions
Alzheimer's disease (AD)mild cognitive impairment due to Alzheimer's disease
Beyond the preview
Go deeper on 2012-003111-58.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003111-58.